Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis

NCT06798415 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hayder Adnan Fawzi